Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve and take on record the ....
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brooks Laboratories has informed the exchanges that its Board of Directors will meet on Friday, 6th February 2026 to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and nine months ended 31st December 2025, along with the Limited Review Report by the Statutory Auditors. The company has also confirmed that the trading window for Directors, Designated Persons, and their immediate relatives remains closed from 1st January 2026 and will reopen 48 hours after the results are declared. No financial figures or outcomes are disclosed in this intimation; this is a standard pre-results notice.
This is a routine regulatory intimation with no direct impact on shareholders. Investors should watch for the actual Q3FY26 numbers on or shortly after 6th February 2026 to gauge the company's quarterly performance and outlook.